A pioneering blood test could predict a woman's risk of developing dementia up to 25 years before symptoms appear, researchers have revealed.
US experts found that higher levels of p-tau217 – a protein linked to the brain changes seen in Alzheimer’s disease – accurately forecast future cognitive problems and dementia.
